When did CG Oncology report Q3 2025 earnings?

CG Oncology (CGON) reported Q3 2025 earnings on November 14, 2025 before market open.

What were CG Oncology's Q3 2025 revenue and EPS?

CG Oncology reported revenue of $1.7M and eps of $-0.57 for Q3 2025.

Did CG Oncology beat estimates in Q3 2025?

Revenue beat the consensus estimate of $59.4K by $1.6M. EPS missed the consensus estimate of $-0.56 by $0.01.

Where can I find CG Oncology's Q3 2025 SEC filings?

You can read the 8-K earnings release (0001193125-25-283108) and the 10-Q periodic report (0001193125-25-283000) directly on SEC EDGAR. The filing index links above go to sec.gov.

CG Oncology CGON Q3 2025 earnings

Reported November 14, 2025 · Before market open

Revenue$1.7MBeat by $1.6M

EPS-$0.57Miss by $0.01

Revenue estimate$59.4K

EPS estimate-$0.56

Next report

Aug 7, 2026 (In 1 week)

Revenue estimate$360.8K

EPS estimate-$0.70

Financials

Q3 2025

Income statement

See full

Revenue$1.7M+3,774%

Operating income-$51.1M-80.7%

Net income-$43.8M-115%

EPS (diluted)-$0.57-90.0%

Balance sheet

See full

Cash & equivalents$45.1M+4.0%

Total debt$7.2M+2,346%

Total equity$687.6M+28.1%

Total assets$729.9M+32.1%

Cash flow

See full

Operating cash flow-$38.9M-144%

CapEx$97.0K—

Free cash flow-$39.0M-145%

Valuation & ratios

Valuation

as of 09/30/25

See full

Market cap$3.07B+22.1%

Enterprise value$3.03B+22.7%

P/S1,412.7×-2,264×

Profitability

See full

Operating margin-8,285.3%-2,407pp

Net margin-6,968%-1,788pp

FCF margin-5,387.7%—

Returns & leverage

See full

Return on equity-24.7%—

Debt / equity0×0.0×

Current ratio22.8×-12.5×

Segments

By product

See full

Commercial And Development Revenue$1.5M—

License And Collaboration Revenue$158.0K+267%

Versus estimates

Revenue

Q1 2026$1.1MBeat by $630.0K Q4 2025$2.3MBeat by $1.8M

Q3 2025$1.7MBeat by $1.6M

Q1 2025$52.0KMiss by $66.2K Q4 2024$456.0KBeat by $332.1K

Diluted EPS

Q1 2026-$0.71Miss by $0.13 Q4 2025-$0.51Beat by $0.10

Q3 2025-$0.57Miss by $0.01

Q2 2025-$0.54Miss by $0.05 Q1 2025-$0.45Miss by $0.06 Q4 2024-$0.48Miss by $0.07

Ask the moment CG Oncology reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did CG Oncology report Q3 2025 earnings?: CG Oncology (CGON) reported Q3 2025 earnings on November 14, 2025 before market open.
What were CG Oncology's Q3 2025 revenue and EPS?: CG Oncology reported revenue of $1.7M and eps of $-0.57 for Q3 2025.
Did CG Oncology beat estimates in Q3 2025?: Revenue beat the consensus estimate of $59.4K by $1.6M. EPS missed the consensus estimate of $-0.56 by $0.01.
Where can I find CG Oncology's Q3 2025 SEC filings?: You can read the 8-K earnings release (0001193125-25-283108) and the 10-Q periodic report (0001193125-25-283000) directly on SEC EDGAR. The filing index links above go to sec.gov.